WO2007147022A2 - Method and apparatus for treating vascular obstructions - Google Patents
Method and apparatus for treating vascular obstructions Download PDFInfo
- Publication number
- WO2007147022A2 WO2007147022A2 PCT/US2007/071156 US2007071156W WO2007147022A2 WO 2007147022 A2 WO2007147022 A2 WO 2007147022A2 US 2007071156 W US2007071156 W US 2007071156W WO 2007147022 A2 WO2007147022 A2 WO 2007147022A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrasound
- frequency
- microns
- amplitude
- approximate range
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/2202—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
- A61B2018/0212—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques using an instrument inserted into a body lumen, e.g. catheter
Definitions
- the present invention relates to method and appaiat ⁇ s foi treating vascular obstruct ions by using ultias ⁇ und eneiu) in conjunction ⁇ ith cryogenic energy and/oi an expandable membet
- PTA percutaneous transluminal angioplasty
- This procedure imoKes inserting a catheter with an expanding balloon into a blood vessel and positioning the balloon o ⁇ er the stenotic lesion to be treated The balloon is then inflated to treat the lesion by compressing the lesion or stretching the walk of the blood vessel.
- PTA percutaneous transluminal angioplasty
- Balloon angioplast> has ad ⁇ aneed into a method that also uses a otoplasty balloon. See, fbt example, V S Pat. Kos 5, 868,735 to ⁇ al ' ontame. 6,290,696 also to ⁇ .aFontaine, and
- l hss method first uses balloon angioplasty treatment to compress the lesion.
- a cryoplasty balloon is inflated and filled with a cooling fluid.
- the cooling fiuid then delivers coo! thermal energy through the ciyoplasty balloon to the treatment area
- the use of cryogenic energy to cool ⁇ he atea after tieatinen ⁇ helps prexenl restenosis m the blood ⁇ essel Similar to the balloon angioplasty method described above, this method also relies on putting pressure on and possibly stretching the walls of the blood ⁇ essel.
- ultrasonic angioplasty Another method used to remove vascular lesions and blockages is ultrasonic angioplasty. This procedure imohes inserting an ultrasonic catheter so that the cathetei tip is positioned against the vascular blockage or lesion.
- the ultrasonic catheter is connected to m ⁇ uSt ⁇ asonic enetgv source via a tiansmission nierabei or guide wue Ultrasonic enejgy is delivered fiom the souice, along the aans ⁇ ussion member or wire, and to the ultrasonic catheter
- the ultiasonjc energy must be deh ⁇ eied at small inten als. generally through pulsed deliver) . because of the risk of tissue damage fiom the heat thermal energ ⁇ that is deh ⁇ ered as a result of using ultrasonic energy.
- the present invention is directed towards method and apparatus for ti eating vascular obstructions by using ultrasonic energv m conjunction with cryogenic energy and/or an expandable member.
- Method and apparatus in accordance with the present invention may meet the abo ⁇ e-mentioned needs and also provide additional ad ⁇ antages and improvements that v-ill be recognized b> those skilled in the art upon review of the ptcsent disclosure
- the present invention comprises a specially designed ultrasound ⁇ ansducer 1 he transducer is inserted into a blood vessel to treat ⁇ asculai obstructions.
- a x-asculai obstiuction include but are not limited to, plaque, lotion, thrombus, clot, tmd blockage
- Freatment of a ⁇ ascular obstruction includes methods such as removal ablation, dilation, or other similar methods or combinations of methods
- the ttansducer delivers uhiasound erseig) to treat a vascular obstruction
- the ultrasound eneigy can be delivered diiectl) to temove a vascular obstruction through mechanical vibration.
- the ultrasound energy can also be delivered thiough the fluid iu the blood vessel to ⁇ emox e a vascular obstruction through cavitation
- cryogenic energy when used m conjunction with ultrasound energy, may have multiple benefits.
- the cryogenic energy may coo ⁇ the area to be treated in order to help loosen the obstruction that is being treated, which then may help the ultrasonic energy more easily, efficiently, and precisely tieat the vascular obstruction
- the cr ⁇ oge ⁇ ic energy may be used to piotect the blood ⁇ essel Delrv ermg ultiasound energy can result in the deli vet y of heat cncigy to the blood ⁇ essel
- the use of crj ogenic enetgy may pio ⁇ ide a cooling effect to prevent damage to (he blood vessel that could result from the heat energy This cooling effect ma ⁇ also allow for continuous deliv ers of uluascmic energy rather than pulsed delivery because these may be less concern with the generation of heat energy
- cryogenic energy niay increase the effectiveness of the delivery of ultrasound energy.
- cryogenic energv may help prevent restenosis on the treated area
- the present invention also permits ultrasound energy to be used in conjunction with an expandable member.
- the ultiasound energy may be able to treat a full vascular occlusion at the same time die expandable member and or ultrasound energj treat a partial ⁇ ascular occlusion, fhe expandable raembei may be in different formats including, but not limited to.
- a balloon at the ei ⁇ i of a transducer a balloon inside a transducer, expandable tubing connecting the transducer to the proximal end. or a hinged transducer
- the hinged transducer may open outward so that it may be able to exert more pressiue on and ensure bettei contact with the obstruction being treated
- a balloon m a> be positioned inside the hinged transducer so that the balloon may inflate when the hinged transducer opens or separates
- the present imention finally permits ultrasound e ⁇ crg ⁇ to be used in conjunction with both cryogenic energy and an expandable member.
- This combination may utilize the beneficial aspects of each of these individual methods described abcne, and theiefoie it ma ⁇ be more effectne because it combines the beneficial aspects of all these methods rather than using any of the methods cither individually or in pairs
- the expandable member maj again include, but is not limited to, a balloon at the end of the transducer, expandable cubing connecting the transducer to the proximal end of the ultrasound device, or a hinged transducer,
- the invention is related to method and apparatus to treat xasc ⁇ iai obstructions by using ultrasonic e ⁇ ergv in combination with cryogenic energy and/or an expandable member
- One aspect of this imention may be to provide a method and device for more effecth e treatment of ⁇ ascular obstructions
- Another aspect of the imention may be to provide a method and de ⁇ ice foi more efficient treatment of vascular obstructions.
- Another aspect of the invention may be to provide a method and de ⁇ ice that poses less risk of damage to blood ⁇ essels during the tieatment of vascular obstructions.
- Figure 1 is a perspective view ultrasound apparatus with an ultrasonic transducer and elongated Figures 2a - 2ra are front cross-sectional views of variations of an elongated tube- Figure 3a — 3c are perspective views of the ultrasound energy as it emanates from the ultrasound transducer and ultrasound tip.
- Figs. 4a-4d are open perspective views of variations of the ultrasound transducer with an elongated tube.
- Figs. 5a - 5b are perspective views of variations of a hinged transducer.
- Figs, 6a - 6e are cross-sectional schematic views of an ultrasound apparatus with an expandable member.
- Figs, 7a - 7b are embodiments of an ultrasound apparatus that has an internal power source.
- the present invention is a method and apparatus for treating vascular obstructions by using ultrasonic energy in conjunction with cryogenic energy or an expandable member, or any combination thereof.
- Preferred embodiments of the present invention in the context of an apparatus and methods are illustrated in the figures and described in detail below.
- FIG. 1 is a perspective view of an ultrasound apparatus with an ultrasound transducer and an elongated tube/catheter for use according to the present invention.
- the apparatus is comprised of an ultrasound generator 1 that is connected to the transducer cable 2,
- This embodiment of the apparatus also comprises a cryogenic source 3 and a cryogenic tube 4.
- the transducer cable 2 and the cryogenic tube 4 are connected to the elongated tube 5.
- the elongated tube 5, which is connected to the ultrasound transducer 6, may serve as the delivery mechanism for the cryogenic energy from the cryogenic source 3 and for the electrical power from the ultrasound generator 1.
- the ultrasound transducer 6 is connected to the ultrasound tip 7.
- Other embodiments may be comprised of a fluid source instead of or in addition to the cryogenic source.
- a fluid such as saline or cryogenic energy may be used to enlarge an expandable member in the apparatus.
- another embodiment could have neither a cryogenic source nor a fluid source.
- Figures 2a - 2i « are from cross-sectional views of variations of the elongated tube 5 for use according to the present invention
- Fig. 2a is an elongated tube 5 with electrical wires 8, a braided guide ⁇ ire 9, a fluid entry lumen 10, a fluid exit lumen IL inner tubing 12, and outer tubing 13.
- the braided guide wire 9 is positioned in the center area of the elongated tube 5, Fig, 2b is an elongated tube 5 with electrical wires S, a fluid entry lumen i ⁇ , a fluid exit lumen H, inner tubing 12, and outer tubing 13 * and a solid guide wire 14,
- the braided guide wire 9 and the solid guide wire 14 may facilitate in the transmission of the elongated tube 5 through a blood vessel
- Fig, 2c is an elongated tube 5 with electrical wires 8, b ⁇ asded guide ⁇ ire 9, a fluid entry lumen H), a fluid exit lumen 11.
- inner tubing 12, and outer tubing 13 The electncal w lies 8 in this embodiment are positioned along the same edge of the outer tubing 13
- Fig. 2d is an elongated tube with electrical wires 8, a fluid entry lumen l ⁇ . a fluid exit lumen 11 , inner tubing ⁇ 2, and outer tubing 13.
- the electrical wires 8 in this embodiment are located at the center area of the elongated tube 5 and act as a guide wit e
- Fig. 2e is an elongated tube 5 with electrical ⁇ ires 8, braided guide ⁇ ire 9, outer tubing 13, and a single fluid lumen 15,
- the electrical wires 8 m this embodiment are located along the same edge of the outing tubing J 3, and the braided guide wire 9 is located at another edge of the outer tubing 13,
- Fig. 2f is an elongated tube 5 with electrical wires 8 and a single fluid lumen 15.
- the electrical wires 8 are located at the edges of the outer tubing 13 and act as a guide wire.
- Fig, 2g is an elongated tube with a braided guide wire 9 and a single fluid lumen 15.
- the braided guide ⁇ iie 9 is located at the edges of the ⁇ utet tubing 13»
- This embodiment does not contain electrical w ires ⁇ n embodiment without electrical wires may be used w ith an ultrasound transducer that has an interna! power source rather than an external power source with connecting electrical wires
- Fig, 2h is an elongated tube 5 with electrical w ires 8 and a solid guide ⁇ ire 14.
- These fluid lumens 16 may be used in any number combination as fluid entry and fluid exit lumens ' 1 he fluid lumens 16 are di ⁇ ⁇ ded by inner tubing 12.
- the solid guide w ire 14 is located in the center area of the elongated tube, and the electrical wires 8 aie located at the edges of the outer tubing i3 Fig. 2i is an elongated tube 5 ⁇ ith electrical w ires S and a braided guide wire 9.
- fluid lumens 16 may be used in any nurabei combination as fluid entry and fluid exit lumens ' 1 he fluid lumens 16 are di ⁇ ⁇ ded by- inner tubing 12, Flic electrical wires 8 and braided guide wire 9 are located at the edges of the outer tubma 13 Fig, 2j is an elongated tube 5 with electrical wires 8 and a solid guide ⁇ ire 14. In this embodiment, there are multiple fluid lumens 16.
- the multiple Ii ⁇ td lumens 16 may be used in any number combination as fluid entry and fluid exit orifices
- the fluid lumens 16 are dh ided b> inner tubing 12.
- the solid guide wire 14 and the electrical wires 8 are located at the edges of the outer tubing 13
- Fig. 2k is an elongated tube 5, with a braided guide wsre % a fluid emr> lumen 10, a fluid exit lumen 3 ⁇ , inner tubing 12. and outer tubing 13. There are no electrical wires m this embodiment The biaided guide wire 9 is located in the center area of the elongated tube 5.
- Fig. 21 is an elongated tube 5 with two braided guide wires 9 located along the edges of outer tubing 13. a fluid entry lumen 10, a fluid exit lumen 1 1, and inner tubing 12. There are no electrical ⁇ vire6 in this embodiment
- Fig. 2m is an elongated tube 5 with two solid guide wires 14 located along the edges of outer tubing 13, and a single fluid lumen 15, There are no electrical wires in this embodiment.
- FIGS. 2a - 2ra are only examples of ⁇ a ⁇ ations of the elongated tube 5 Other similar embodiments or combinations of these embodiments may also be utilized.
- An elongated tube may comprise no guide wire, a single guide w iie, or multiple guide wires.
- the tube may also comprise no electrical wiies, a single electrical w ire, or multiple electrical wires I he elongated tube may also comprise no lumen, a single lumen, or multiple lumens
- Figure 3a - 3c are perspective Mews of the uitiasound eneigy as it emanates from the ultrasound transducer 6 and uitiasound tip 7
- Fig. 3a shows ultrasound energy 17 as it emanates from the iadiai side of the uitiasound apparatus.
- the ultrasound energy 17 that emanates from the radial side of an ultrasound transducer and ultrasound tip are generally radsal waves.
- Fig. 3t> shows ultrasound energy 17 as it emanates from the distal end of the ultrasound apparatus.
- the ultrasound energy 17 that emanates from the distal end are geneially longitudinal wax es .
- Fig. 3c shows ultrasound etiergv 17 emanating from the ultrasound transducer d and ultrasound tip 7, Some sheai w a ⁇ es may emanate along with the longitudinal and iadial wax es
- Figs, 4a-4d are open perspecth e ⁇ Jews of vacations of the iiltiasoimd transducer 6 for use according to the present i mention
- Each of the embodiments show a in these ⁇ a ⁇ ations comp ⁇ ise an elongated tube 5» which Ls computed of electrical wires 8, a biaided guide wire 9, inner tubing 12, outei tubing 13, and an ultrasound tip 7
- Fig. 4a is an open perspeeth e ⁇ iew of an ultrasound apparatus comprised of an ultrasound transducci 6 that is compitsed of multiple piezoelectric disks ⁇ 8 Fig.
- FIG. 4b is an open perspecm e ⁇ iew of an ultrasound appaiarus comp ⁇ sed of an ultrasound transducer 6 that is comprised of two piezoelectric disks 19
- Fig. 4c is an open perspective view of an ultrasound apparatus comprised of an ultrasound transducer 6 that is comprised of one single piezoelectric disk 20, Fig.
- FIG. 4d is an open perspective v iew of an ultrasound apparatus comprised of an ultrasound transducer 6 ihat is comprised of two hahes of piezoelectric disks 2 ⁇ [ " he two hah es of pie/oeiectuc disks 21 ma ⁇ be bonded together or hinged together for use as a hinged transducer, or the two halves of piezoelectric disks 21 may be separable.
- Figs, 5a and 5b are perspect ⁇ e ⁇ iew s of ⁇ a ⁇ ations of a hinged transducer 22.
- a hinged transducer 22 can be used as an expandable member according to the present invention.
- the hinged transducer 22 may open so that a balloon may expand from inside the transducer to contact the blood vessel Additionally, the hinged transducer 22 may expand to contact the blood vessel itself without a balloon expanding Tins direct contact may allow fot more effective treatment of a vascular obstruction because of v arious benefits that may include opening the blood ⁇ essel, compressing an obstruction, and rnoie effective delnety of ultrasound energy
- Fig. 5a is a hinged ultrasound transducer 22.
- Fig. 5b is a hinged uhrasound transducer 22, which is comprised of two sepaiate hahes of piezoelectric disks 21 that are connected v ia a pivot point 24
- Figs. 6a - 6e are cross-sectional schematic siews of an ultrasound apparatus with an expandable member.
- Fig. 6a is an ultrasound apparatus comprised of an ultrasound transducer 6 and an ultrasound tip 7.
- the elongated tube 5 is comprised of outer tubing 13, which is comprised of a thick section 25 and a narrow section 26, Hie thick section 25 is a certain thickness so that it remains a stable and is less expandable if a fluid flows through it
- the narrow section 26 ss thinnei than the thick section 25 so that it JS able to expand radial K 2?
- the narrow section 26 acts as an expandable member because it is able to expand iadialiy 27.
- the elongated tube 5 in this embodiment is comp ⁇ sed of a single fluid lumen 14 as shown in fig, 2e and fig. 2f, Fig, 6b is an ultrasound apparatus comprised of an ultiasound transduces 6 and an ultrasound tip 7
- the outer tubing ⁇ 3 is comprised so that it can expand 28 if a fluid flows through it 1 here is also a proteethe sheath 28 o ⁇ er the outer tubing 13 so that only a portion of outer tubing ⁇ 3 is able to expand radially 27 Fig.
- 6v is an ultiasound apparatus comprised of an ultrasound ttansdueer 6 and an ult ⁇ asound tip 7 I he outei tubing 13 is comprised of a certain thickness so that it remains a stable si/e if a fluid flows through it.
- This embodiment is comprised of an expandable mernbes 29 is able to expand 30 at the distal end
- the expandable member 29 could be expandable tubing, an inflatable ba ⁇ foon, or another similar expanding material.
- the elongated tube 5 in this embodiment is comprised of eiectiicai ⁇ ires 8 and a bt aided guide wiie 9 as shewn m f ⁇ g. 2 ⁇ I
- Fig. 6d is an. ultrasound apparatus comprised of a hinged ultiasound transducer 22 and an ultrasound tip 6,
- the hinged transducer 22 is comp ⁇ sed of two hakes of piezoelectric disks that are connected by a pnot point 24.
- the hinged ultrasound transducer 22 opens to alicm an expandable member to expand 31
- the expandable member with a hinged transducer 22 may be an inflatable balloon positioned inside the hinged transducer 22 that may be inflated.
- the expandable member may also be the hinged transduce* 22 itself that opens to contact the walls of a blood vessel and/or a vascular obstruction.
- Fig. 6e is an ultrasound apparatus comprised of an ultrasound oamducei 6 and an ultrasound tip 7,
- the ultrasound transducer 6 is comp ⁇ sed of two halves of piezoelectric disks 21 that arc unconnected.
- the piezoelectric disks separate to allow an expandable member to expand 32
- the expandable member may be an inflatable balloon located inside the transducer 6.
- Figs. 7a and 7b are embodiments of an ultiasound apparatus accoidi ⁇ *g to the ptese ⁇ t in ⁇ ention that are comprised of an internal power source.
- FIg, 7a depicts an ultrasound transducer 6 and an ultiasound tip 33 that has an internal power source 34.
- the internal power source 34 may be used in lieu of the external ultiasound generator 1 shown in Fig. 1
- This embodiment does not comprise an expandable membct Qyogenic enetgy may still be delixered through the elongated tube 5 in conjunction with the ultrasound energy
- Fig. 7b depicts an ultrasound transducer 6 and ultrasound tip 33 that has an internal ⁇ m ⁇ er source 34.
- the elongated tube 5 is comprised of outer tubing 13. which *s comp ⁇ sed of a thick section 25 and a nauow section 26, llie thick section 25 is a certain thickness so that it remains a stable and is lest expandable if a fluid Slows through u
- the ultrasound apparatus shown m Fig. 1 dclners ultiasonnd enetgv to ttcat ⁇ astulai obstructions
- Thevenezu invention relates to a special iv designed ⁇ iti abound tiansducer I be tsamdiicer is nisei ted into a blood vessel to treat xas ⁇ ilat obsttutttons Fxamples of v asculai ohsUuetiom indude, but are not limited to, plaques iesums tfciorabo.se:> clob and blockages
- Treatment of a vascular obstruction includes methods such as temos al ablation dilation, or 0 olhej similar methods oi combinations of methods I he transdutei dehv eis ultrasound energs to Ueat a ⁇ asculai obstiucuon Uie uit ⁇ asound ene
- Thewagiu unention also ielates to a specialK designed elongated tube for use with the ultrasound traiisducei Tlie elongated lube is designed for inserting the «lt ⁇ ji6 ⁇ imd t ⁇ msducer 0 uuo a blood ⁇ essel S lie tube ⁇ iav a Ku sene other functions that mav include, but ate not limited to delrv e ⁇ ng the ultiasound pow er from the ultiasound geneiatoi to the transducer deli ⁇ eung L.r ⁇ ogeu!c eneigv d ⁇ ln e ⁇ ng fluid to enlaige au enlatgeable menibei oi expanding iadialK to sen c as> an enlaigcable member t itrasou ⁇ d etiergv mav be deliv ered m conjunction w ith civ ogemc eneig ⁇ I he
- cryogenic energy rna> be used to protect the blood ⁇ essel Delhering ultrasound energy can result in the delix er ⁇ of heat energ> to the blood vessel.
- cryogenic energy may pros i ⁇ e a cooling effect Lo p ⁇ e ⁇ ent damage to the blood ⁇ essel that could result ftort ⁇ the heat euergy fhis cooling effect may also allow for continuous delivers of ultrasonic energy rather than pulsed delners because there may be less concent with the generation of heat enetgy Additionally, the cryogenic energy may increase the effectn ersess of the delrvery of ultrasound energy. Finally, similar to its use with a balloon angioplasty dc ⁇ ice, the cryogenic energy may help prevent restenosis on the treated area.
- Ultrasound energy may be used m conjunction with an expandable member 1 be expandable member may have a similar effect in treating a vascular obstruction as a balloon angioplasty device
- Ultrasound energy, when used in conjunction with an expandable member may allow for a more effeeth c compression of a vascular obstruction.
- the use of ultrasound energy requhes less pressure to be exerted from the expandable member, thereby reducing the stress imposed on a blood vessel, t-urthe ⁇ nore, the ultrasound energy may be able to treat a full vascular occlusion at tiie same time the expandable member and or ultrasound energy treat a partial vascular occlusion.
- the expandable member may be in different formats including, but not limited to, a balloon at the end of a transducer, a balloon inside a transducer, expandable tubing connecting the transducer to the proximal end, or a hinged transducei ' I he hinged transducer may open outward so that it may be able to exert more pressure on and ensure better contact with the obstruction being treated. Additionally, a balloon may be positioned inside the hinged ttarisdueer so that the balloon ma ⁇ inflate when the hinged transducer opens or sepaiates
- ultrasonic energy may be used in conjunction with both cryogenic energy and an expandable member
- This combination may utilize the beneficial aspects of each of these indh idual methods described above, and therefore it may be more effectn e because it combines the beneficial aspects of all these methods rather than using any of the methods either individually or in pairs.
- the expandable member may be comprised of a balloon at the end of the transducer, expandable tubing connecting the transducer to the proximal end, or a hinged transducer. Other expandable members may be similarly effective.
- the ultrasonic energy mas be deli ⁇ ered before, during, or after enlarging the expandable member, oi any combination theieof TSie ultrasonic energy may also be delheted before, dunng. or after the delivery of cryogenic energy, 01 any combination thereof
- the cryogenic energy ina> also be delneted before, during, or after enlarging of the expandable member, or any combination thereof
- the intensity of die ultrasound energy can be controlled through a ⁇ ariatiou in the ultrasound pammeteis Mich as the frequency, the amplitude and the treatment time
- the frequency range for the ultrasound energy is 16 SdI/ to 40 MIk
- the tow -frequency ultrasound range is I fc kHz - 200 kll/
- the preferred low ⁇ ftequeney ultrasound sange is 30 kl ⁇ / — !00 kl l/
- the recommend !ow-ftequenc ⁇ ultias ⁇ und value is 80 kl i/
- the medium frequency ultrasound range is 200 kHz to 700 kHz, and the recommended medium frequency ultrasound ⁇ al ⁇ e is 200 U 1/
- the high-frequency ultrasound range is 0 7 MI 1/ 40 MI I/
- the recommend high- frequency ultrasound valise is 5MlIz.
- the amplitude of the ultrasound energj can be 1 micron and above, ⁇ he preferred low -frequency ultrasound amplitude is in range of 2 microns to 250 microns, with the most preferred low-frequency amplitude to be m the range of 20 microns to 60 mi ⁇ ons. and the recommended low -frequency amplitude value is 20 30 microns.
- the preferred amplitude range for of the high- frequency ultrasound is 1 micron to 10 microns, and tlie most preferred amplitude range for the high-fiequency ultiasound is 2 microns to 5 microns.
- the preferred method of treatment uses low-frequency ultrasound.
Abstract
Method and device for treating vascular obstruction using ultrasonic energy in combination with, cryogenic energy and/or an expandable member is disclosed. Ultrasound energy is delivered from a special ly designed ultrasound transducer that is inserted in a blood vessel . Ultrasound energy can be delivered in conjunction with cryogenic energy. Ultrasound energy can also be delivered in conjunction with, an expandable member such as expandable tubing, a hinged transducer, or a balloon. Ultrasound energy can also be delivered in conjunction with both cryogenic energy and an expandable member. The use of ultrasound energy in combination with cryogenic energy and/or an expandable member can treat a vascular obstruction.
Description
Method and Apparatus for Treating Vascular Obstructions
BACKGROUND OF THE INVENTION Field .of the Im en tion;
The present invention relates to method and appaiatυs foi treating vascular obstruct ions by using ultiasøund eneiu) in conjunction \\ ith cryogenic energy and/oi an expandable membet
Vascular lesions ha\e been traditionally treated by using percutaneous transluminal angioplasty (PTA) procedures, or more commonly known as -"balloon'' angioplasty This procedure imoKes inserting a catheter with an expanding balloon into a blood vessel and positioning the balloon o\ er the stenotic lesion to be treated The balloon is then inflated to treat the lesion by compressing the lesion or stretching the walk of the blood vessel. One drawback of this method is that it does not remove the lesion or plaque. Restenosis can occur wheie the blood \essel narrows once again, which would then tequire anothet treatment This technique can be used to treat both the coionaiy artery and other blood vessels. One problem with this procedure is that it relies on putting pressure on and possibls stretching the walls of the blood vessel This m turn can cause stress on the blood \ essel
Balloon angioplast> has ad\aneed into a method that also uses a otoplasty balloon. See, fbt example, V S Pat. Kos 5, 868,735 to ϊ al'ontame. 6,290,696 also to ϊ.aFontaine, and
6,290,696 to Joye. l hss method first uses balloon angioplasty treatment to compress the lesion.
After the angioplasty treatment, a cryoplasty balloon is inflated and filled with a cooling fluid.
The cooling fiuid then delivers coo! thermal energy through the ciyoplasty balloon to the treatment area The use of cryogenic energy to cool {he atea after tieatinenϊ helps prexenl restenosis m the blood \ essel Similar to the balloon angioplasty method described above, this method also relies on putting pressure on and possibly stretching the walls of the blood \essel.
Another method used to remove vascular lesions and blockages is ultrasonic angioplasty. This procedure imohes inserting an ultrasonic catheter so that the cathetei tip is positioned against the vascular blockage or lesion. The ultrasonic catheter is connected to m\
uStτasonic enetgv source via a tiansmission nierabei or guide wue Ultrasonic enejgy is delivered fiom the souice, along the aansπussion member or wire, and to the ultrasonic catheter The ultrasonic energy \ ibiates the ultrasonic catheter tip This \ ihration in the catheter tip ablates and removes the vascular blockage or lesion by mechanical impact and eav station Because the ultrasonic eneig) must tun el ovet a long distance, resulting m an attenuation of the energ}, a great amount of ultrasonic energy most be delivered from the ultrasonic sαuice This can iesult in the ultiasound tiansmission membei 01 wnε breaking OJ fiactuung dm ing use. \dditrønaik , the ultiasonjc energy must be deh\ eied at small inten als. generally through pulsed deliver) . because of the risk of tissue damage fiom the heat thermal energ} that is deh\ ered as a result of using ultrasonic energy.
I ' S Patent Ko 5,474,530 to I'avsafat et at and L S Patenϊ No 5,324,255 to Paasafai et al disclose a method that uses ultrasonic angioplasty with balloon angioplasty The ultrasound energy is used onlv to create a passage way through winch a balloon cathetei can travel if the opening in the blood \ essel is not wide enough for the balloon catheter Passafar't. uses of ultrasound eneigj- is ouh to create a passage for the balloon, and theiefore still faces the drawback of the pressure on a blood \essel from an inflated balloon.
Current methods used to tieat vascular obstruction rel> on potting prcsbutc on a blood vessel or delivery heat theimal energy to the blood vessel 1 hese methods can iesiilt in stress on a blood \ essel or in tissue damage fϊom heat energy Theieibie. there is a need for a method and device that utilizes the benefits of uluasυnic enetg\ to remove vascular obstructions but that does not pose the risk of heat thermal damage to the blood vessel. There is an additional need foj a method and de\ see that can utilize ultrasonic energy ni conjunction w ith a balloon angioplasty de\ ice so that less pressure is exerted on the blood vessel from an Inflated balloon. Finally, there is a need for a method and device that can combine the benefits of balloon angioplasty, ultrasonic angioplasty . and cryoplasty.
Si:\iM ARY OF THE IKVCXTΪOX
The present invention is directed towards method and apparatus for ti eating vascular obstructions by using ultrasonic energv m conjunction with cryogenic energy and/or an expandable member. Method and apparatus in accordance with the present invention may meet
the abo\e-mentioned needs and also provide additional ad\ antages and improvements that v-ill be recognized b> those skilled in the art upon review of the ptcsent disclosure
The present invention comprises a specially designed ultrasound πansducer 1 he transducer is inserted into a blood vessel to treat \asculai obstructions. Examples of a x-asculai obstiuction include but are not limited to, plaque, lotion, thrombus, clot, tmd blockage
Freatment of a \ascular obstruction includes methods such as removal ablation, dilation, or other similar methods or combinations of methods The ttansducer delivers uhiasound erseig) to treat a vascular obstruction The ultrasound eneigy can be delivered diiectl) to temove a vascular obstruction through mechanical vibration. The ultrasound energy can also be delivered thiough the fluid iu the blood vessel to ϊemox e a vascular obstruction through cavitation
The present indention allows foi ultrasound energ) io be delivered in conjunction with cryogenic energy. The use of cryogenic energy, when used m conjunction with ultrasound energy, may have multiple benefits. First, the cryogenic energy may cooϊ the area to be treated in order to help loosen the obstruction that is being treated, which then may help the ultrasonic energy more easily, efficiently, and precisely tieat the vascular obstruction Second, the cr\ ogeπic energy may be used to piotect the blood \ essel Delrv ermg ultiasound energy can result in the deli vet y of heat cncigy to the blood \ essel The use of crj ogenic enetgy may pio\ ide a cooling effect to prevent damage to (he blood vessel that could result from the heat energy This cooling effect ma\ also allow for continuous deliv ers of uluascmic energy rather than pulsed delivery because these may be less concern with the generation of heat energy
Additionally, the cryogenic energy niay increase the effectiveness of the delivery of ultrasound energy. Finally, similar to its use v\ifh a balloon angioplasty de\ ice. the cryogenic energv may help prevent restenosis on the treated area
The present invention also permits ultrasound energy to be used in conjunction with an expandable member. The expandable memhei maj ha\e a srmilai effect in treating a vascular obstruction as a balloon angioplasty device. Lltrasound energy, when used in conjunction with an expandable member, max allow for a more effective compression of a vascular obstruction 1 lie use of ultiasound energy requites less pressure to be exerted from the expandable mernbei, thereby t educing the stress imposed on a blood \ essel Furthermore, the ultiasound energy may be able to treat a full vascular occlusion at the same time die expandable member and or
ultrasound energj treat a partial \ ascular occlusion, fhe expandable raembei may be in different formats including, but not limited to. a balloon at the eiκi of a transducer, a balloon inside a transducer, expandable tubing connecting the transducer to the proximal end. or a hinged transducer The hinged transducer may open outward so that it may be able to exert more pressiue on and ensure bettei contact with the obstruction being treated Additionally, a balloon m a> be positioned inside the hinged transducer so that the balloon may inflate when the hinged transducer opens or separates
The present imention finally permits ultrasound eπcrg\ to be used in conjunction with both cryogenic energy and an expandable member. This combination may utilize the beneficial aspects of each of these individual methods described abcne, and theiefoie it ma\ be more effectne because it combines the beneficial aspects of all these methods rather than using any of the methods cither individually or in pairs The expandable member maj again include, but is not limited to, a balloon at the end of the transducer, expandable cubing connecting the transducer to the proximal end of the ultrasound device, or a hinged transducer, The invention is related to method and apparatus to treat xascυiai obstructions by using ultrasonic eπergv in combination with cryogenic energy and/or an expandable member
One aspect of this imention may be to provide a method and device for more effecth e treatment of \ ascular obstructions
Another aspect of the imention may be to provide a method and de\ ice foi more efficient treatment of vascular obstructions.
Another aspect of the invention may be to provide a method and de\ ice that poses less risk of damage to blood \essels during the tieatment of vascular obstructions.
These and other aspects of the imention will become more apparent from the written descriptions and flguies below.
BRIEF DBSCRiPIlC)N OF THE DRAWINGS
The present Invention will be shown and described with reference to the drawings of preferred embodiments and clearly understood in details.
Figure 1. is a perspective view ultrasound apparatus with an ultrasonic transducer and elongated Figures 2a - 2ra are front cross-sectional views of variations of an elongated tube- Figure 3a — 3c are perspective views of the ultrasound energy as it emanates from the ultrasound transducer and ultrasound tip.
Figs. 4a-4d are open perspective views of variations of the ultrasound transducer with an elongated tube. Figs. 5a - 5b are perspective views of variations of a hinged transducer.
Figs, 6a - 6e are cross-sectional schematic views of an ultrasound apparatus with an expandable member.
Figs, 7a - 7b are embodiments of an ultrasound apparatus that has an internal power source.
DETAILED DESCRl PTK)N OF THE INVEN TION
The present invention is a method and apparatus for treating vascular obstructions by using ultrasonic energy in conjunction with cryogenic energy or an expandable member, or any combination thereof. Preferred embodiments of the present invention in the context of an apparatus and methods are illustrated in the figures and described in detail below.
Figure 1 is a perspective view of an ultrasound apparatus with an ultrasound transducer and an elongated tube/catheter for use according to the present invention. The apparatus is comprised of an ultrasound generator 1 that is connected to the transducer cable 2, This embodiment of the apparatus also comprises a cryogenic source 3 and a cryogenic tube 4. The transducer cable 2 and the cryogenic tube 4 are connected to the elongated tube 5. The elongated tube 5, which is connected to the ultrasound transducer 6, may serve as the delivery mechanism for the cryogenic energy from the cryogenic source 3 and for the electrical power from the ultrasound generator 1. The ultrasound transducer 6 is connected to the ultrasound tip 7. Other embodiments may be comprised of a fluid source instead of or in addition to the cryogenic source. A fluid such as saline or cryogenic energy may be used to enlarge an expandable member in the apparatus. Additionally, another embodiment could have neither a cryogenic source nor a fluid source.
Figures 2a - 2i« are from cross-sectional views of variations of the elongated tube 5 for use according to the present invention, Fig. 2a is an elongated tube 5 with electrical wires 8, a braided guide \\ ire 9, a fluid entry lumen 10, a fluid exit lumen IL inner tubing 12, and outer tubing 13. The electrical wires 8, positioned at the edges of the outer tubing 13 in this embodiment, act as the power source for the ultrasound transducer 6. The braided guide wire 9 is positioned in the center area of the elongated tube 5, Fig, 2b is an elongated tube 5 with electrical wires S, a fluid entry lumen iθ, a fluid exit lumen H, inner tubing 12, and outer tubing 13* and a solid guide wire 14, The braided guide wire 9 and the solid guide wire 14 may facilitate in the transmission of the elongated tube 5 through a blood vessel
Fig, 2c is an elongated tube 5 with electrical wires 8, bϊ asded guide \\ ire 9, a fluid entry lumen H), a fluid exit lumen 11. inner tubing 12, and outer tubing 13 The electncal w lies 8 in this embodiment are positioned along the same edge of the outer tubing 13
Fig. 2d is an elongated tube with electrical wires 8, a fluid entry lumen lθ. a fluid exit lumen 11 , inner tubing Ϊ2, and outer tubing 13. The electrical wires 8 in this embodiment are located at the center area of the elongated tube 5 and act as a guide wit e
Fig. 2e is an elongated tube 5 with electrical \\ ires 8, braided guide \\ ire 9, outer tubing 13, and a single fluid lumen 15, The electrical wires 8 m this embodiment are located along the same edge of the outing tubing J 3, and the braided guide wire 9 is located at another edge of the outer tubing 13, There is a single fluid lumen IS that may allow for both the cntiy and the exit of a fluid
Fig. 2f is an elongated tube 5 with electrical wires 8 and a single fluid lumen 15. In this embodiment, the electrical wires 8 are located at the edges of the outer tubing 13 and act as a guide wire. Fig, 2g is an elongated tube with a braided guide wire 9 and a single fluid lumen 15. The braided guide Λ\ iie 9 is located at the edges of the υutet tubing 13» This embodiment does not contain electrical w ires Λn embodiment without electrical wires may be used w ith an ultrasound transducer that has an interna! power source rather than an external power source with connecting electrical wires Fig, 2h is an elongated tube 5 with electrical w ires 8 and a solid guide \\ ire 14. In this embodiment, theie arc multiple fluid lumens 16. These fluid lumens 16 may be used in any number combination as fluid entry and fluid exit lumens '1 he fluid lumens 16 are di\ ϊded by inner tubing 12. The solid guide w ire 14 is located in the center area of the elongated tube, and the electrical wires 8 aie located at the edges of the outer tubing i3 Fig. 2i is an elongated tube 5 \\ ith electrical w ires S and a braided guide wire 9. In this embodiment, theie arc multiple fluid lumens 16. These fluid lumens 16 may be used in any nurabei combination as fluid entry and fluid exit lumens '1 he fluid lumens 16 are di\ ϊded by- inner tubing 12, Flic electrical wires 8 and braided guide wire 9 are located at the edges of the outer tubma 13
Fig, 2j is an elongated tube 5 with electrical wires 8 and a solid guide \\ ire 14. In this embodiment, there are multiple fluid lumens 16. The multiple Iiυtd lumens 16 may be used in any number combination as fluid entry and fluid exit orifices The fluid lumens 16 are dh ided b> inner tubing 12. The solid guide wire 14 and the electrical wires 8 are located at the edges of the outer tubing 13
Fig. 2k is an elongated tube 5, with a braided guide wsre % a fluid emr> lumen 10, a fluid exit lumen 3 ϊ, inner tubing 12. and outer tubing 13. There are no electrical wires m this embodiment The biaided guide wire 9 is located in the center area of the elongated tube 5.
Fig. 21 is an elongated tube 5 with two braided guide wires 9 located along the edges of outer tubing 13. a fluid entry lumen 10, a fluid exit lumen 1 1, and inner tubing 12. There are no electrical \vire6 in this embodiment
Fig. 2m is an elongated tube 5 with two solid guide wires 14 located along the edges of outer tubing 13, and a single fluid lumen 15, There are no electrical wires in this embodiment.
Figures 2a - 2ra are only examples of \ aπations of the elongated tube 5 Other similar embodiments or combinations of these embodiments may also be utilized. An elongated tube may comprise no guide wire, a single guide w iie, or multiple guide wires. The tube may also comprise no electrical wiies, a single electrical w ire, or multiple electrical wires I he elongated tube may also comprise no lumen, a single lumen, or multiple lumens
Figure 3a - 3c are perspective Mews of the uitiasound eneigy as it emanates from the ultrasound transducer 6 and uitiasound tip 7 Fig. 3a shows ultrasound energy 17 as it emanates from the iadiai side of the uitiasound apparatus. The ultrasound energy 17 that emanates from the radial side of an ultrasound transducer and ultrasound tip are generally radsal waves. Fig. 3t> shows ultrasound energy 17 as it emanates from the distal end of the ultrasound apparatus. The ultrasound energy 17 that emanates from the distal end are geneially longitudinal wax es . Fig. 3c shows ultrasound etiergv 17 emanating from the ultrasound transducer d and ultrasound tip 7, Some sheai w a\es may emanate along with the longitudinal and iadial wax es
Figs, 4a-4d are open perspecth e \ Jews of vacations of the iiltiasoimd transducer 6 for use according to the present i mention Each of the embodiments show a in these \ aπations compϊise an elongated tube 5» which Ls computed of electrical wires 8, a biaided guide wire 9,
inner tubing 12, outei tubing 13, and an ultrasound tip 7 Fig. 4a is an open perspeeth e \ iew of an ultrasound apparatus comprised of an ultrasound transducci 6 that is compitsed of multiple piezoelectric disks Ϊ8 Fig. 4b is an open perspecm e \ iew of an ultrasound appaiarus compπsed of an ultrasound transducer 6 that is comprised of two piezoelectric disks 19, Fig. 4c is an open perspective view of an ultrasound apparatus comprised of an ultrasound transducer 6 that is comprised of one single piezoelectric disk 20, Fig. 4d is an open perspective v iew of an ultrasound apparatus comprised of an ultrasound transducer 6 ihat is comprised of two hahes of piezoelectric disks 2Ϊ ["he two hah es of pie/oeiectuc disks 21 ma\ be bonded together or hinged together for use as a hinged transducer, or the two halves of piezoelectric disks 21 may be separable.
Figs, 5a and 5b are perspectπ e \ iew s of \ aπations of a hinged transducer 22. A hinged transducer 22 can be used as an expandable member according to the present invention. The hinged transducer 22 may open so that a balloon may expand from inside the transducer to contact the blood vessel Additionally, the hinged transducer 22 may expand to contact the blood vessel itself without a balloon expanding Tins direct contact may allow fot more effective treatment of a vascular obstruction because of v arious benefits that may include opening the blood \ essel, compressing an obstruction, and rnoie effective delnety of ultrasound energy Fig. 5a is a hinged ultrasound transducer 22. which is comprised of two separate halves of piezoelectric disks 21 that are connected via a thin mcmbiane 23 Fig. 5b is a hinged uhrasound transducer 22, which is comprised of two sepaiate hahes of piezoelectric disks 21 that are connected v ia a pivot point 24
Figs. 6a - 6e are cross-sectional schematic siews of an ultrasound apparatus with an expandable member. Fig. 6a is an ultrasound apparatus comprised of an ultrasound transducer 6 and an ultrasound tip 7. The elongated tube 5 is comprised of outer tubing 13, which is comprised of a thick section 25 and a narrow section 26, Hie thick section 25 is a certain thickness so that it remains a stable and is less expandable if a fluid flows through it The narrow section 26 ss thinnei than the thick section 25 so that it JS able to expand radial K 2? In tins embodiment, the narrow section 26 acts as an expandable member because it is able to expand iadialiy 27. The elongated tube 5 in this embodiment is compπsed of a single fluid lumen 14 as shown in fig, 2e and fig. 2f,
Fig, 6b is an ultrasound apparatus comprised of an ultiasound transduces 6 and an ultrasound tip 7 The outer tubing Ϊ3 is comprised so that it can expand 28 if a fluid flows through it 1 here is also a proteethe sheath 28 o\er the outer tubing 13 so that only a portion of outer tubing Ϊ3 is able to expand radially 27 Fig. 6v is an ultiasound apparatus comprised of an ultrasound ttansdueer 6 and an ultτasound tip 7 I he outei tubing 13 is comprised of a certain thickness so that it remains a stable si/e if a fluid flows through it. This embodiment is comprised of an expandable mernbes 29 is able to expand 30 at the distal end The expandable member 29 could be expandable tubing, an inflatable baϊfoon, or another similar expanding material. The elongated tube 5 in this embodiment is comprised of eiectiicai \\ ires 8 and a bt aided guide wiie 9 as shewn m fϊg. 2ΪI
Fig. 6d is an. ultrasound apparatus comprised of a hinged ultiasound transducer 22 and an ultrasound tip 6, The hinged transducer 22 is compπsed of two hakes of piezoelectric disks that are connected by a pnot point 24. The hinged ultrasound transducer 22 opens to alicm an expandable member to expand 31 The expandable member with a hinged transducer 22 may be an inflatable balloon positioned inside the hinged transducer 22 that may be inflated. The expandable member may also be the hinged transduce* 22 itself that opens to contact the walls of a blood vessel and/or a vascular obstruction.
Fig. 6e is an ultrasound apparatus comprised of an ultrasound oamducei 6 and an ultrasound tip 7, In this embodiment, the ultrasound transducer 6 is compπsed of two halves of piezoelectric disks 21 that arc unconnected. The piezoelectric disks separate to allow an expandable member to expand 32 The expandable member may be an inflatable balloon located inside the transducer 6.
Figs. 7a and 7b are embodiments of an ultiasound apparatus accoidiτ*g to the pteseπt in\ention that are comprised of an internal power source. FIg, 7a depicts an ultrasound transducer 6 and an ultiasound tip 33 that has an internal power source 34. The internal power source 34 may be used in lieu of the external ultiasound generator 1 shown in Fig. 1 This embodiment does not comprise an expandable membct Qyogenic enetgy may still be delixered through the elongated tube 5 in conjunction with the ultrasound energy Fig. 7b depicts an ultrasound transducer 6 and ultrasound tip 33 that has an internal ρm\ er source 34. The elongated tube 5 is comprised of outer tubing 13. which *s compπsed of a thick section 25 and a
nauow section 26, llie thick section 25 is a certain thickness so that it remains a stable and is lest expandable if a fluid Slows through u The nanυw section 26 a> thmnei than the {hick section 25 so that it is able to expand radraiiv 27 (o this embodiment, the naπow section 26 acts as an expandable member because it ss able to expand radially 27,
S The ultrasound apparatus shown m Fig. 1 dclners ultiasonnd enetgv to ttcat \astulai obstructions The pieseiu invention relates to a special iv designed υiti abound tiansducer I be tsamdiicer is nisei ted into a blood vessel to treat xasπilat obsttutttons Fxamples of v asculai ohsUuetiom indude, but are not limited to, plaques iesums tfciorabo.se:> clob and blockages Treatment of a vascular obstruction includes methods such as temos al ablation dilation, or 0 olhej similar methods oi combinations of methods I he transdutei dehv eis ultrasound energs to Ueat a \asculai obstiucuon Uie uitιasound eneι^> can be dein eied directly oi it can be delivered thsough tbe fluid m the blood \essel, theιcb\ remo\mg the ^ abcular obstruction tiiiough mechanical vibration oi cavitation I he ultiasound energy mav be deii\eied fiom the radial side of the ultiasound transducer and or ultrasound tip, horn the distal end of tbe S ultrasound tip, oi from the enlajgeabϊe meinbei, or anv coTubmation theieof I he uiltasouud tiansducet ma> also be powered b\ an external powet souice such as an ultiasound generatoi oi it im have an internal powei source as shown ni Fig. 7,
The pieseiu unention also ielates to a specialK designed elongated tube for use with the ultrasound traiisducei Tlie elongated lube is designed for inserting the «ltτji6θimd tπmsducer 0 uuo a blood \essel S lie tube πiav a Ku sene other functions that mav include, but ate not limited to delrv eπng the ultiasound pow er from the ultiasound geneiatoi to the transducer deli\eung L.r\ogeu!c eneigv dεln eπng fluid to enlaige au enlatgeable menibei oi expanding iadialK to sen c as> an enlaigcable member t itrasouαd etiergv mav be deliv ered m conjunction w ith civ ogemc eneig\ I he ^ ei v ogemc eneig) max be delneied to the \ astulai obstruction andoi to the blood vessel, the civ ogemc eneigv mav be delneied through the elongated tube tbe transducer the ultrasound tip oi an expandable membei ϊ he crvogemc enetgv may be delivered before during and oi aftei the deln eiv oi the ultrasonic enetgv
The use of ciyαgensc eneig>s when used m conjunction with ultrasound energ\ ma\ 0 have multiple benefits* I irsi the civ ogemc eneigv ma\ coo! tbe area to be tteated in order to
help loosen the obstruction that is being treated, which then niay help the ultrasonic energy more easily, efficiently, and precisely tieat the vascular obstruction Second, the cryogenic energy rna> be used to protect the blood \essel Delhering ultrasound energy can result in the delix er\ of heat energ> to the blood vessel. The use of cryogenic energy may pros iάe a cooling effect Lo pιe\ ent damage to the blood \ essel that could result ftortϊ the heat euergy fhis cooling effect may also allow for continuous delivers of ultrasonic energy rather than pulsed delners because there may be less concent with the generation of heat enetgy Additionally, the cryogenic energy may increase the effectn ersess of the delrvery of ultrasound energy. Finally, similar to its use with a balloon angioplasty dc\ ice, the cryogenic energy may help prevent restenosis on the treated area.
Ultrasound energy may be used m conjunction with an expandable member 1 be expandable member may have a similar effect in treating a vascular obstruction as a balloon angioplasty device Ultrasound energy, when used in conjunction with an expandable member may allow for a more effeeth c compression of a vascular obstruction. The use of ultrasound energy requhes less pressure to be exerted from the expandable member, thereby reducing the stress imposed on a blood vessel, t-urtheπnore, the ultrasound energy may be able to treat a full vascular occlusion at tiie same time the expandable member and or ultrasound energy treat a partial vascular occlusion. The expandable member may be in different formats including, but not limited to, a balloon at the end of a transducer, a balloon inside a transducer, expandable tubing connecting the transducer to the proximal end, or a hinged transducei 'I he hinged transducer may open outward so that it may be able to exert more pressure on and ensure better contact with the obstruction being treated. Additionally, a balloon may be positioned inside the hinged ttarisdueer so that the balloon ma\ inflate when the hinged transducer opens or sepaiates
Finally, ultrasonic energy may be used in conjunction with both cryogenic energy and an expandable member This combination may utilize the beneficial aspects of each of these indh idual methods described above, and therefore it may be more effectn e because it combines the beneficial aspects of all these methods rather than using any of the methods either individually or in pairs. The expandable member may be comprised of a balloon at the end of the transducer, expandable tubing connecting the transducer to the proximal end, or a hinged transducer. Other expandable members may be similarly effective. The ultrasonic energy mas be deli\ered before, during, or after enlarging the expandable member, oi any combination
theieof TSie ultrasonic energy may also be delheted before, dunng. or after the delivery of cryogenic energy, 01 any combination thereof The cryogenic energy ina> also be delneted before, during, or after enlarging of the expandable member, or any combination thereof
The intensity of die ultrasound energy can be controlled through a \ ariatiou in the ultrasound pammeteis Mich as the frequency, the amplitude and the treatment time The frequency range for the ultrasound energy is 16 SdI/ to 40 MIk The tow -frequency ultrasound range is I fc kHz - 200 kll/, the preferred low~ftequeney ultrasound sange is 30 klϊ/ — !00 kl l/, and the recommend !ow-ftequenc\ ultiasυund value is 80 kl i/ The medium frequency ultrasound range is 200 kHz to 700 kHz, and the recommended medium frequency ultrasound \ alυe is 200 U 1/, The high-frequency ultrasound range is 0 7 MI 1/ 40 MI I/, the more preferred high-frequency uiuasøund iange ts 3 VUIz 5 MH/, and the recommend high- frequency ultrasound valise is 5MlIz. The amplitude of the ultrasound energj can be 1 micron and above, ϊhe preferred low -frequency ultrasound amplitude is in range of 2 microns to 250 microns, with the most preferred low-frequency amplitude to be m the range of 20 microns to 60 miαons. and the recommended low -frequency amplitude value is 20 30 microns The preferred amplitude range for of the high- frequency ultrasound is 1 micron to 10 microns, and tlie most preferred amplitude range for the high-fiequency ultiasound is 2 microns to 5 microns. The preferred method of treatment uses low-frequency ultrasound.
Although specific embodiments and methods υf use have been illustrated and desctibed net em, it \\ ill be appreciated by those of ordinal y skill in the art that any arrangement that is calculated to achieve the same purpose may be substituted for the specific embodiments and methods shown, it is to be understood that the abo\e description ss intended to be illusttatn e and not restrietn e. Combinations of the above embodiments and other embodiments as well as combinations of the abov e methods of use and other methods of use will be apparent to those ha\ ing skill in the art upon review of the present disclosure. The scope of the present imentioπ should be determined w ith reference to the appended claims, along with the full scope of equivalents to which such claims are entitled
Claims
CLAIMS 1 claim
1 ) A method fot ultrasonic angioplasty w ith an expandable raembei , comprising the steps of a) insetting an ultrasound tiansducei w uh an expandable membct into a biood \essel, b) positioning the ultrasound Uansducei on aml'oi neai a \ascular obstruction c) enlarging the expandable membet , and d) delnermg uitiasound to the ucmitv of a \asculas obstruction c) v\ her em the iiStiasoimd is. capable of ticatmg a \ ascuϊai obstiiiction
2) The method accoidmg to tlaim i iurthei comprising die step of generating said ulti abound 3 ) I he method according to claim S. wheiem said ultt abound compπses low ~fiequene\ ultiasound with a frequenc) within the appioxtmaie iange of H> kHz 200 U I/
4) The method according to claim 1, vjiciem said ultrasound comprises low -fiequencs ultrasound with a piεfeπed frequency within the approximate range of ^O kH/ ~ 100 M l/
5) I he method accoidmg to claim 1 w herein said ultrasound composes low-freqυencv ultrasound with a iccommended ftequcnc\ of appioximately HO kHz
6) The method accoidmg to claim i wherein said ulttasound coinpπses incdιum-fteqυenc> ultiasound with a frequenc) within the appioximate tange of 200 kHz ^oo KH/
7) I he method according to claim 1, wheiem said uhiasotmd comprises medmm-frcqitencv ultrasound with a iecomiυended ftequencv of appioximatelv 200 ill/ S) I he method dccoiding to claim I , wheicin said tmrasotmd compiles hιgh~ftcquenc> ultrasound witii a fiequciic\ withm the approximate iange of 700 kHz - 40 MHz
9) The method accoidmg to tlaim ! wherein said ulti abound comprises high-frequency ultiasound with a prefeueU fiequenc\ withm the appioxmiate iange of 3 MlU 5 MI k lOHIie method according to claim 1 wheiem said ultiasound comprises hfgh-ftequency ultiasound \\ ith a recommended frequence of approximately ^ \tH? ϊ 1 ) I he method accoidmg to claim \ , w heiem tiie ultiasound amplitude is at least 1 micioii
12>Th.e method according to claim 1. whεiein said iiltiasound comprises lov.~fιequenc\ ultrasound v\ Hh an amplitude within the appiuximate range of 2 niicrom - 250 microns
1 3) I he method accoiding to claim 1 , wheiem said ultrasound comprises 1ov\-freφιenc>' ultrasound with a piefeπed amplitude within the approximate range of 20 microns 60 S microns
S 4} The method according to claim L wheiem said ulti abound comprises low-frequency ultrasound with a recommended amplitude of approximately 20 microns — 30 microns
15) I he method according to claim 1, wherein said ultrasound comprises medium-frequency ultrasound with a piefeπed amplitude within die approximate iatige of 2 microns 60
10 microns.
16) I he method according to claim L wherein said ultrasound comprises medium-fiequency ultiasυund with a most prefened amplitude within the approximate range of 5 micions 30 microns
1 ^) The method accotdmg to claim ! , v\ herein said αluasoαnd comprises medium- frequency ! 5 ultrasound with a lecomroended. ampluude of appιoximatel> 5 micions - 10 microns.
18) I he method according to claim 5. w herein said ulrrasound comprises hϊgli-frequenc\ ultta&ound with a prefcncd amplitude within the approximate range of i micron ~ 10 microns
19) I he method according to claim L wherein said ultrasound comprises high-frequenc> 0 ultrasound \\ Hh a most preferred amplitude within the apptυximate range of 2 micron;, - ^ microns,
20) I he method according to claim ! . wherein enlarging the expandable member is in the maiinei of ladiallv expanding an elongated tube
21 1 The method according to claim L wheiem enlarging the expandable member is tn the 5 manner of expanding a hinged transducer
22) The method according to claim 1 , w heiein enlarging the expandable member n> in the manner of inflating a balloon.
2^ ) The method according to claim 1. wheiem the uittasound is delneied befoie dimng. or aftc: enlatgnig the expandable member, 01 any combination thereof
24) A method for uiπasornc et\ opϊasty , cυrπpπsmg the steps of a) I user Ling an uittasυnje tiansducei into a blood \es^el b) Positioning the ultiasonic transduce! on υι near a \asculai obstruction. c) DeIn ciuig ulti abound to the \-icimtv of a xascular obstruction, and d) Delπ ei ing cryogenic energy to the \ icinity of a \ ascular obstruction, c) Wherein the ultrasound is capable of ti eating a \ ascular obstruction
25} The method according to claim 24 fiπthei compiling the step of geueiatmg said ulttasoiind
2ft ) The method according to claim 24, further compiling the step of generating said cnogenic energy wheiem said generated cryogenic energ\ JS capable of enhancing the lemovai of a \ascular obstiuction
27) The method according to claim 24, wherein »aκ1 ultrasound comprises iow-fieqiicncv ultiasound with a fiequencx within the appϊoxmiate iange of 16 kH/ 200 U l/
28} The method according to claim 24, wheiem said ultiasound comprises iow-fiequency ultrasound v\ Hh a pieferred fiequciicj within the approximate iangc of ^O klϊz - H)O IJI/
2Q) The method dccoidsng to claim 24, v\heιem said ultiasound eompuses low-frequencv ultrasound with a iecoramended fiequcnc\ of appioximatelv 80 kHz 30) The method accoiding to claim 24. \\ herein ^aκ1 ultiasound composes mediιan-ήequenc\ ultiasound with a Acqucncy within the appioxurtate iange of 200 kϊl/ - 700 klϊ/
31 ) The method according to claim 24, wheiem said ultrasound comprises raedium-frequenev ultiasound \\ ith a recommended frequence of approximately 200 kHz
32) The method accoidmg to claim 24, whciesn said ultrasound composes high-frequency ultrasound with a fiequεnc v w ithm the appi oximate iange of 700 LI I/ 4(3 M 11/
33) The method accoiding to claim 24. wherein saκ.1 ultiasound composes high-frequenc> ultiasound with a prefened Jϊequency withm the appioximatc iange of 3 Mlϊ/ - 5 Kil l/
34}11ie method according to claim 24, wherein said ultrasound comprises high-frequency ultrasound Λ\ Uh a recommended frequency of approximate!} 5 Vf ϊi/
35) I he method accoiding to ciasro 24, w herein the ultrasound ampluude is at lea&i I mieiυn.
36) "I he method accoiding to claim 24, wheiein said ultrasound comprises low -frequency ultrasound w ith an amplitude within the approximate range of 2 microns 250 microns
37) The method according to claim 24. wherein said ultrasound comprises low-frequency ultrasound with a preferred amplitude w ithin the appioxirna.e iange of 20 microns 60 microns
38) The method according to claim 24, wherein said ultrasound comprises low- frequency ultrasound with a recommended amplitude of approximately 20 micions 30 microns.
3^) I he method according to claim 24. wherein said ultrasound comprises medium-frequency ultrasound with a preferred amplitude within the approximate range of 2 micions ~ 60 microns
40 j The method according to claim 24, wherein said ultrasound comprises medium-frequency ultrasound \x ith a most preferred amplitude within the approximate range of 5 microns - 30 microns,
41 ) T he method according to claim 24. wherein said ultrasound comprises medium-frequency ultrasound with a recommended amplitude of approximately 5 microns 10 microns.
42}The. method according to claim 24, wherein said ultrasound comprises high-frequency ultrasound with a preferred amplitude within the approximate range of I micron - 10 microns
43) T he method according to claim 24, wherein said ultrasound compπses high-frequency ultrasound with a most preferred amplitude w ithin the approximate range of 2 micions - 5 microns 44 ) The method according to claim 24, w herein the ultrasound is delivered befoie. during, or after the delivery of the cryogenic energy, or an} combination thereof.
45) Λ method for uiuasonie otoplasty with an expandable member, comprising the steps of. a) inserting an ultrasound transducer into a blood \essel.
b) Positioning the ultrasound transducer on or near a vascular obstruction, c) Enlarging an expandable member; d) Delivering ultrasound to the \ icinitj of a vascular obstruction, and e) Deli vet ing cryogenic energy to the vicinity of a \ ascular obstruction 1) Whαelπ the ultrasound is capable of treating a \ ascular obstruction
46) I he method according to claim 45. further comprising the step of generating said ultrasound
47) The method according to claim 45, further comprising the step of generating cryogenic energy, wherein said cryogenic energy is capable of enhancing the treatment of a \ ascular obstruction
48) The method according to claim 45, wherein said ultrasound comprises low-frequency ultrasound with a frequency within the apptoxnxiate range of 16 k H/ 20(3 kHz.
4^) The method according to claim 45. wherein said ultrasound comprises low-frequency ultrasound with a preferred frequency within the approximate range of 30 kl l/ - 100 kl\z 50} The method according to claim 45, uheiein said uhiasound comprises low-frequency, ultrasound Λ\ ith a recommended frequency of approximately 80 kHz.
51 ) The method according to claim 45, wherein said ultrasound comprises medium-frequency ultrasound with a frequency within the apptoxnxiate range of 200 Id I/ 7(30 kHz
52) The method according to claim 45. wherein said ultrasound comprises medium-frequency ultrasound with a recommended frequency of approximately 200 kf 1/
53 ) The method according to claim 45. wherein said ultrasound comprises high-fiequency ultrasound with a frequency within the approximate range of 7OO kHz — 40 MHz.
54) The method according to claim 45, wherein said ultrasound comprises high-frequency ultrasound with a prefeπed frequency within the approximate tange of 3 Mi l/ 5 MH/ 55) I he method according to claim 45, wherein said ultrasound compπses high-frequency ultrasound with a recommended frequency of approximately 5 λflϊz.
56 ) The method according to claim 45. wherein the ultrasound amplitude is at least 1 micron
57 } The method according to claim 45, wherein said ultrasound comprises low-frequency ultrasound with an amplitude within the approximate range of 2 microns - 250 microns.
58) The method according to claim 45, wherein said ultrasound comprises low-frequency ultrasound with a preferred amplitude within the approximate range of 20 microns - 60 microns.
59} The method according to claim 45, wherein said ultrasound comprises low-frequency ultrasound with a recommended amplitude of approximately 20 microns — 30 microns.
60) The method according to claim 45, wherein said ultrasound comprises medium-frequency ultrasound with a preferred amplitude within die approximate range of 2 microns - 60 microns.
6 i ) The method according to claim 45, wherein said ultrasound comprises medium- frequency ultrasound with a most preferred amplitude within the approximate range of 5 microns - 30 microns.
62) The method according to claim 45, wherein said ultrasound comprises medium- frequency ultrasound with a recommended amplitude of approximately 5 microns - 10 microns.
63) The method according to claim 45. wherein said ultrasound comprises high-frequency ultrasound with a preferred amplitude within the approximate range of i micron ~ 10 microns.
64) The method according to claim 45, wherein said ultrasound comprises high-frequency ultrasound with a most preferred amplitude within the approximate range of 2 microns - 5 microns.
65) The method according to claim 45, wherein the ultrasound is delivered before, during, or after the delivery of the cryogenic energy, or any combination thereof.
66 } The method according to claim 45. wherein the cryogenic energy is delivered before, during, or after enlarging of the expandable member, or any combination thereof.
67) The method according to claim 45, wherein the ultrasound is delivered before, during, or after enlarging of the expandable member, or any combination thereof.
68}11ie method according to claim 45, wherein enlarging the expandable member is in the manner of radially expanding an elongated tube.
69) The method according to claim 45, wherein enlarging the expandable member is in the manner of expanding a hinged transducer. 70} The method according to claim 45, wherein enlarging the expandable member is in the manner of inflating a balloon.
71 } Ao ultrasound device for treating a \asculai" obstruction, comprised of a) an ultrasound power source and a transducer for producing ultrasound energy; b) wherein the ultrasound transducer is specially designed for insertion into a blood vessel; c) wherein the ultrasound transducer delivers ultrasound energy to the v icinity of a vascular obstruction, and d) wherein the ultrasound is capable of treating a vascular obstruction,
72} The apparatus according to claim 71, wherein the power source and transducer generate the ultrasound energy with particular ultrasound parameters indicative of an intensity capable of treating a vascular obstruction ,
73)The method according to claim 71, wherein said ultrasound comprises low-frequency ultrasound with a frequency within the approximate range of 16 kl iz 200 kHz,
74) The method according to claim 71 , wherein said ultrasound comprises low-frequency ultrasound with a preferred frequency within the approximate range of 30 kHz - 100 kHz. 75) The method according to claim 71, wherein said ultrasound comprises low-frequency ultrasound with, a recommended frequency of approximately 80 kliz.
76) The method according to claim 71, wherein said ultrasound comprises medium-frequency ultrasound with a frequency within the approximate range of 200 kliz - 700 kHz.
77) The method according to claim 71 , wherein said ultrasound comprises medium- frequency ultrasound with a recommended frequency of approximately 200 kHz,
78) The method according to claim 71, wherein said ultrasound comprises high-frequency ultrasound with a frequency within the approximate range of 700 kHz - 40 MHz.
79}11ie method according to claim ? L wherein said ultrasound comprises high-frequency ultrasound vuth a pieferred frequency within the approximate range of 3 MI i/ - 5 MIIΛ
80) I he method accoiding to ciasro 71 , v\ herein said uittasound comprises high -frequency ultrasound with a recommended fiequency of apptoximatel} 5 .NtH/. 81 ) The method according to claim 71. \\ herein the ultrasound amplitude is at least 1 micron
S2)The method according to claim 71. wherein said ultrasound comprises iuw~fiequeney ultiasound with ao amplitude within the approximate range of 2 micioπs 250 microns.
83 )1 lie method according to claim 71, wherein said ultrasound comprises low-frequency ultrasound \\ Hh a pieferred amplitude within the approximate range of 20 microns — 60 microns.
S4) I he method according to claim 71. wherein said ultrasound comprises low -frequency ultrasound with a recommended amplitude of approximately 20 microns* ~ 30 microns.
85} The method according to claim 71, wherein said ultrasound comprises medium- frequency ultrasound with a preferred amplitude within the approximate range of 2 microns - 60 microns
86) T he method accotding to claim 71 wheiein said ultrasound compiises medium-frequency ultrasound w ith a most preferred amplitude within the approximate range of 5 microns 30 micions.
8?}11ie method according to claim 71, wherein said ultrasound comprises medium-frequency ultrasound with a recommended amplitude of approximately 5 microns - 10 microns.
HK) The method accoidmg to claim 71 , wherein said ultrasound comprises high-frequency ultrasound with a pieferred amplitude within the approximate range of I micron K) microns
S^) The method according to claim 7 L wherein said ultrasound comprises high-frequency ultrasound with a most preferred amplitude within the approximate range of 2 micions 5 microns
90) "I he uiuasound device according to claim 71. wherein the power souiee is internal m the transducer
1 i ) The ultrasound de\ ice aeeoiding to claim 71 \\ herein the pov\ er source is externa! to the tramducet.
92) I he ultrasound dc\ see according to claim 71 further compiled of a fluid soiπce
93) "I he uluasound device according to claim 92, wherein the fluid source is a cryogenic source 94) I he ultrasound de\ ice according to claim ? 1. further comprised of an elongated tube connecting the ultrasound transducer to the proximal end of the ultrasound dc\ see.
951 The ultrasound device accoiding to claim 71 , ibrthei comprised of an expandable memhei
96} The ultrasound de\ ice according to claim °-5 wheiein the expandable member is a hinged transducer. 9"1) The ultrasound device according to claim 95. wherein the expandable member is an inflatable balloon
98) I he ultrasound de\ ice according to claim 95. v\ herein the balloon is positioned on the distal end of the transduce..
99) The ultrasound device according to claim 95, wherein the expandable member is a iadially expandable elongated tube connecting the transducer to the proximal end of the ultrasound device.
100) An elongated tube comprised of a) Outer tubing. b} An interna! lumen or lumens; c) An internal guide wire or guide wires; d) wherein the internal lumen or lumens are capable of delivering a fluid, and e) wherein the guide wire oi guide whes aie capable of facilitating the ttansmission of the elongated rube through a blood vessel.
101) The elongated tube according to claim 100. \\ herein the guide w ire or guide wires are solid, braided, or another similarly effective form.
102) The elongated tube according to claim 100, further comprised of electrical \\ ires
103) The elongated tube according to claim 100, v, heiein the gutde wire or guide wires are electrical wires.
104} The elongated tube according to claim 100. wherein the outei tubing ts made of an expandable material, a non-expandable mateπa!, oi a combination of expandable and non- expandable materia!
S 05) The elongated tube according to claim 100, funhei comprised of inner tubing
106) 'I he elongated tube according to claim 100, fuuhei eompiised of a sheath o\ er the outer tubing.
!07) The elongated tube according to claim 100. wherein the sheath ccnerb a pot {ton of {he outer tube
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/454,018 | 2006-06-15 | ||
US11/454,018 US20080097251A1 (en) | 2006-06-15 | 2006-06-15 | Method and apparatus for treating vascular obstructions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007147022A2 true WO2007147022A2 (en) | 2007-12-21 |
WO2007147022A3 WO2007147022A3 (en) | 2008-11-20 |
Family
ID=38832831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/071156 WO2007147022A2 (en) | 2006-06-15 | 2007-06-14 | Method and apparatus for treating vascular obstructions |
Country Status (2)
Country | Link |
---|---|
US (1) | US20080097251A1 (en) |
WO (1) | WO2007147022A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016124090B4 (en) * | 2016-12-12 | 2021-01-28 | Otto-Von-Guericke-Universität Magdeburg | Invasive medical instrument |
Families Citing this family (154)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
AU2004285412A1 (en) | 2003-09-12 | 2005-05-12 | Minnow Medical, Llc | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
JP5479901B2 (en) | 2006-10-18 | 2014-04-23 | べシックス・バスキュラー・インコーポレイテッド | Induction of desired temperature effects on body tissue |
EP2455034B1 (en) | 2006-10-18 | 2017-07-19 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
CA2666661C (en) | 2006-10-18 | 2015-01-20 | Minnow Medical, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
US8241324B2 (en) * | 2008-03-03 | 2012-08-14 | Eilaz Babaev | Ultrasonic vascular closure device |
US20100036294A1 (en) * | 2008-05-07 | 2010-02-11 | Robert Mantell | Radially-Firing Electrohydraulic Lithotripsy Probe |
US10702293B2 (en) | 2008-06-13 | 2020-07-07 | Shockwave Medical, Inc. | Two-stage method for treating calcified lesions within the wall of a blood vessel |
JP5636363B2 (en) * | 2008-06-13 | 2014-12-03 | ディージェイティー、 エルエルシー | Shock wave balloon catheter device |
US9072534B2 (en) | 2008-06-13 | 2015-07-07 | Shockwave Medical, Inc. | Non-cavitation shockwave balloon catheter system |
US9180280B2 (en) * | 2008-11-04 | 2015-11-10 | Shockwave Medical, Inc. | Drug delivery shockwave balloon catheter system |
US9044618B2 (en) | 2008-11-05 | 2015-06-02 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
CN102271603A (en) | 2008-11-17 | 2011-12-07 | 明诺医学股份有限公司 | Selective accumulation of energy with or without knowledge of tissue topography |
US20100160903A1 (en) * | 2008-12-22 | 2010-06-24 | Yosef Krespi | Process and system for treating a vascular occlusion or other endoluminal structure |
US7967814B2 (en) * | 2009-02-05 | 2011-06-28 | Icecure Medical Ltd. | Cryoprobe with vibrating mechanism |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
EP2600784B1 (en) | 2010-08-05 | 2021-12-29 | Medtronic Ireland Manufacturing Unlimited Company | Cryoablation apparatuses, systems, and methods for renal neuromodulation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US20120158104A1 (en) | 2010-10-26 | 2012-06-21 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US20120259269A1 (en) | 2011-04-08 | 2012-10-11 | Tyco Healthcare Group Lp | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
CN103930061B (en) | 2011-04-25 | 2016-09-14 | 美敦力阿迪安卢森堡有限责任公司 | Relevant low temperature sacculus for restricted conduit wall cryogenic ablation limits the device and method disposed |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
EP4101399A1 (en) | 2011-08-05 | 2022-12-14 | Route 92 Medical, Inc. | System for treatment of acute ischemic stroke |
EP2765942B1 (en) | 2011-10-10 | 2016-02-24 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
EP2775948B1 (en) | 2011-11-08 | 2018-04-04 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US8574247B2 (en) | 2011-11-08 | 2013-11-05 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
EP2779929A1 (en) | 2011-11-15 | 2014-09-24 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
WO2013096913A2 (en) | 2011-12-23 | 2013-06-27 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
WO2013101452A1 (en) | 2011-12-28 | 2013-07-04 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US20150088113A1 (en) | 2012-04-27 | 2015-03-26 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices for renal neuromodulation and associated systems and methods |
US9241752B2 (en) | 2012-04-27 | 2016-01-26 | Medtronic Ardian Luxembourg S.A.R.L. | Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9642673B2 (en) | 2012-06-27 | 2017-05-09 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
ES2715678T3 (en) | 2012-08-06 | 2019-06-05 | Shockwave Medical Inc | Low profile electrodes for an angioplasty shock wave catheter |
CA2881184C (en) | 2012-08-06 | 2019-06-04 | Shockwave Medical, Inc. | Shockwave catheter |
US9138249B2 (en) | 2012-08-17 | 2015-09-22 | Shockwave Medical, Inc. | Shock wave catheter system with arc preconditioning |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US9333000B2 (en) | 2012-09-13 | 2016-05-10 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9522012B2 (en) | 2012-09-13 | 2016-12-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
EP2895095A2 (en) | 2012-09-17 | 2015-07-22 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
JP6074051B2 (en) | 2012-10-10 | 2017-02-01 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Intravascular neuromodulation system and medical device |
WO2014143571A1 (en) | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
CA2905107C (en) | 2013-03-11 | 2020-04-14 | Northgate Technologies Inc. | Unfocused electrohydraulic lithotripter |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US20140276615A1 (en) * | 2013-03-14 | 2014-09-18 | Volcano Corporation | Delivery catheter having imaging capabilities |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
JP2016524949A (en) | 2013-06-21 | 2016-08-22 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation having a rotatable shaft |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
WO2015002787A1 (en) | 2013-07-01 | 2015-01-08 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
EP3019106A1 (en) | 2013-07-11 | 2016-05-18 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
EP3049007B1 (en) | 2013-07-19 | 2019-06-12 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
WO2015013205A1 (en) | 2013-07-22 | 2015-01-29 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
JP6159888B2 (en) | 2013-08-22 | 2017-07-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Flexible circuit with improved adhesion to renal neuromodulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
CN105530885B (en) | 2013-09-13 | 2020-09-22 | 波士顿科学国际有限公司 | Ablation balloon with vapor deposited covering |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
WO2015057521A1 (en) | 2013-10-14 | 2015-04-23 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
EP3057520A1 (en) | 2013-10-15 | 2016-08-24 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
JP6259099B2 (en) | 2013-10-18 | 2018-01-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Balloon catheter comprising a conductive wire with flexibility, and related uses and manufacturing methods |
CN105658163B (en) | 2013-10-25 | 2020-08-18 | 波士顿科学国际有限公司 | Embedded thermocouple in denervation flexible circuit |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
WO2015103617A1 (en) | 2014-01-06 | 2015-07-09 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
EP3102136B1 (en) | 2014-02-04 | 2018-06-27 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US10492842B2 (en) | 2014-03-07 | 2019-12-03 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring and controlling internally administered cryotherapy |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US9730715B2 (en) | 2014-05-08 | 2017-08-15 | Shockwave Medical, Inc. | Shock wave guide wire |
WO2016126974A1 (en) | 2015-02-04 | 2016-08-11 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
US10426497B2 (en) | 2015-07-24 | 2019-10-01 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
WO2017087195A1 (en) | 2015-11-18 | 2017-05-26 | Shockwave Medical, Inc. | Shock wave electrodes |
EP3419528B1 (en) * | 2016-02-24 | 2023-06-07 | Incept, LLC | Enhanced flexibility neurovascular catheter |
US10226265B2 (en) | 2016-04-25 | 2019-03-12 | Shockwave Medical, Inc. | Shock wave device with polarity switching |
AU2017339980B2 (en) | 2016-10-06 | 2022-08-18 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
US10357264B2 (en) | 2016-12-06 | 2019-07-23 | Shockwave Medical, Inc. | Shock wave balloon catheter with insertable electrodes |
US10653426B2 (en) | 2017-01-06 | 2020-05-19 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
CN110392591B (en) | 2017-01-10 | 2022-06-03 | 92号医疗公司 | Aspiration catheter system and method of use |
US10441300B2 (en) | 2017-04-19 | 2019-10-15 | Shockwave Medical, Inc. | Drug delivery shock wave balloon catheter system |
US11020135B1 (en) | 2017-04-25 | 2021-06-01 | Shockwave Medical, Inc. | Shock wave device for treating vascular plaques |
US10966737B2 (en) | 2017-06-19 | 2021-04-06 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
US10709462B2 (en) | 2017-11-17 | 2020-07-14 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
US11103262B2 (en) | 2018-03-14 | 2021-08-31 | Boston Scientific Scimed, Inc. | Balloon-based intravascular ultrasound system for treatment of vascular lesions |
AU2019262972A1 (en) | 2018-05-01 | 2020-10-15 | Incept, Llc | Devices and methods for removing obstructive material from an intravascular site |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
CN115999019A (en) | 2018-05-17 | 2023-04-25 | 92号医疗公司 | Aspiration catheter system and method of use |
US11819229B2 (en) | 2019-06-19 | 2023-11-21 | Boston Scientific Scimed, Inc. | Balloon surface photoacoustic pressure wave generation to disrupt vascular lesions |
WO2019245746A1 (en) | 2018-06-21 | 2019-12-26 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
WO2020010310A1 (en) | 2018-07-06 | 2020-01-09 | Imperative Care, Inc. | Sealed neurovascular extendable catheter |
US11622779B2 (en) | 2018-10-24 | 2023-04-11 | Boston Scientific Scimed, Inc. | Photoacoustic pressure wave generation for intravascular calcification disruption |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
US11717139B2 (en) | 2019-06-19 | 2023-08-08 | Bolt Medical, Inc. | Plasma creation via nonaqueous optical breakdown of laser pulse energy for breakup of vascular calcium |
US11660427B2 (en) | 2019-06-24 | 2023-05-30 | Boston Scientific Scimed, Inc. | Superheating system for inertial impulse generation to disrupt vascular lesions |
US20200406009A1 (en) | 2019-06-26 | 2020-12-31 | Boston Scientific Scimed, Inc. | Focusing element for plasma system to disrupt vascular lesions |
EP4034006A1 (en) | 2019-09-24 | 2022-08-03 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
WO2021076642A1 (en) | 2019-10-15 | 2021-04-22 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
US11583339B2 (en) | 2019-10-31 | 2023-02-21 | Bolt Medical, Inc. | Asymmetrical balloon for intravascular lithotripsy device and method |
US11633272B2 (en) | 2019-12-18 | 2023-04-25 | Imperative Care, Inc. | Manually rotatable thrombus engagement tool |
US11259821B2 (en) | 2019-12-18 | 2022-03-01 | Imperative Care, Inc. | Aspiration system with accelerated response |
CA3162704A1 (en) | 2019-12-18 | 2021-06-24 | Imperative Care, Inc. | Methods and systems for treating venous thromboembolic disease |
US11633224B2 (en) | 2020-02-10 | 2023-04-25 | Icecure Medical Ltd. | Cryogen pump |
US11672599B2 (en) | 2020-03-09 | 2023-06-13 | Bolt Medical, Inc. | Acoustic performance monitoring system and method within intravascular lithotripsy device |
EP4117762A1 (en) | 2020-03-10 | 2023-01-18 | Imperative Care, Inc. | Enhanced flexibility neurovascular catheter |
US20210290286A1 (en) | 2020-03-18 | 2021-09-23 | Bolt Medical, Inc. | Optical analyzer assembly and method for intravascular lithotripsy device |
US11707323B2 (en) | 2020-04-03 | 2023-07-25 | Bolt Medical, Inc. | Electrical analyzer assembly for intravascular lithotripsy device |
US11896249B2 (en) * | 2020-07-02 | 2024-02-13 | Gyrus Acmi, Inc. | Lithotripsy system having a drill and lateral emitter |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
US11672585B2 (en) | 2021-01-12 | 2023-06-13 | Bolt Medical, Inc. | Balloon assembly for valvuloplasty catheter system |
US11648057B2 (en) | 2021-05-10 | 2023-05-16 | Bolt Medical, Inc. | Optical analyzer assembly with safety shutdown system for intravascular lithotripsy device |
US11806075B2 (en) | 2021-06-07 | 2023-11-07 | Bolt Medical, Inc. | Active alignment system and method for laser optical coupling |
US11839391B2 (en) | 2021-12-14 | 2023-12-12 | Bolt Medical, Inc. | Optical emitter housing assembly for intravascular lithotripsy device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3942519A (en) * | 1972-12-26 | 1976-03-09 | Ultrasonic Systems, Inc. | Method of ultrasonic cryogenic cataract removal |
US6514249B1 (en) * | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US20040097996A1 (en) * | 1999-10-05 | 2004-05-20 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode |
US20040243119A1 (en) * | 1999-08-23 | 2004-12-02 | Cryocath Technologies Inc. | Endovascular cryotreatment catheter |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3433226A (en) * | 1965-07-21 | 1969-03-18 | Aeroprojects Inc | Vibratory catheterization apparatus and method of using |
US3565062A (en) * | 1968-06-13 | 1971-02-23 | Ultrasonic Systems | Ultrasonic method and apparatus for removing cholesterol and other deposits from blood vessels and the like |
DE2219790C3 (en) * | 1972-04-22 | 1974-11-07 | R Pohlman | Device for generating brittle fractures in hard stones |
US4528979A (en) * | 1982-03-18 | 1985-07-16 | Kievsky Nauchno-Issledovatelsky Institut Otolaringologii Imeni Professora A.S. Kolomiiobenka | Cryo-ultrasonic surgical instrument |
US4808153A (en) * | 1986-11-17 | 1989-02-28 | Ultramed Corporation | Device for removing plaque from arteries |
US4841977A (en) * | 1987-05-26 | 1989-06-27 | Inter Therapy, Inc. | Ultra-thin acoustic transducer and balloon catheter using same in imaging array subassembly |
US4870953A (en) * | 1987-11-13 | 1989-10-03 | Donmicheal T Anthony | Intravascular ultrasonic catheter/probe and method for treating intravascular blockage |
US4924863A (en) * | 1988-05-04 | 1990-05-15 | Mmtc, Inc. | Angioplastic method for removing plaque from a vas |
US4936281A (en) * | 1989-04-13 | 1990-06-26 | Everest Medical Corporation | Ultrasonically enhanced RF ablation catheter |
US5662701A (en) * | 1989-08-18 | 1997-09-02 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
ZA917281B (en) * | 1990-09-26 | 1992-08-26 | Cryomedical Sciences Inc | Cryosurgical instrument and system and method of cryosurgery |
US5139496A (en) * | 1990-12-20 | 1992-08-18 | Hed Aharon Z | Ultrasonic freeze ablation catheters and probes |
US5304115A (en) * | 1991-01-11 | 1994-04-19 | Baxter International Inc. | Ultrasonic angioplasty device incorporating improved transmission member and ablation probe |
US5324255A (en) * | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
US5267954A (en) * | 1991-01-11 | 1993-12-07 | Baxter International Inc. | Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels |
JP2998505B2 (en) * | 1993-07-29 | 2000-01-11 | 富士写真光機株式会社 | Radial ultrasonic scanner |
US5427118A (en) * | 1993-10-04 | 1995-06-27 | Baxter International Inc. | Ultrasonic guidewire |
US5509417A (en) * | 1994-12-19 | 1996-04-23 | Hewlett Packard Company | Method and apparatus for phased array coupling ultrasonic energy into an acoustic waveguide wire |
DE19504261A1 (en) * | 1995-02-09 | 1996-09-12 | Krieg Gunther | Angioplasty catheter for dilating and / or opening blood vessels |
DE19527018C1 (en) * | 1995-07-24 | 1997-02-20 | Siemens Ag | Ultrasonic transducer |
US5749848A (en) * | 1995-11-13 | 1998-05-12 | Cardiovascular Imaging Systems, Inc. | Catheter system having imaging, balloon angioplasty, and stent deployment capabilities, and method of use for guided stent deployment |
US5713916A (en) * | 1996-02-28 | 1998-02-03 | Hewlett Packard Company | Method and system for coupling acoustic energy using shear waves |
US5813998A (en) * | 1996-02-28 | 1998-09-29 | Hewlett-Packard Company | Method and system for coupling acoustic energy using an end-fire array |
US5976123A (en) * | 1996-07-30 | 1999-11-02 | Laser Aesthetics, Inc. | Heart stabilization |
US5836896A (en) * | 1996-08-19 | 1998-11-17 | Angiosonics | Method of inhibiting restenosis by applying ultrasonic energy |
US5925074A (en) * | 1996-12-03 | 1999-07-20 | Atrium Medical Corporation | Vascular endoprosthesis and method |
US5899898A (en) * | 1997-02-27 | 1999-05-04 | Cryocath Technologies Inc. | Cryosurgical linear ablation |
US6235019B1 (en) * | 1997-02-27 | 2001-05-22 | Cryocath Technologies, Inc. | Cryosurgical catheter |
US5868735A (en) * | 1997-03-06 | 1999-02-09 | Scimed Life Systems, Inc. | Cryoplasty device and method |
US6012457A (en) * | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6024740A (en) * | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6245064B1 (en) * | 1997-07-08 | 2001-06-12 | Atrionix, Inc. | Circumferential ablation device assembly |
US6117101A (en) * | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US5971979A (en) * | 1997-12-02 | 1999-10-26 | Odyssey Technologies, Inc. | Method for cryogenic inhibition of hyperplasia |
US6391026B1 (en) * | 1998-09-18 | 2002-05-21 | Pro Duct Health, Inc. | Methods and systems for treating breast tissue |
US6149596A (en) * | 1998-11-05 | 2000-11-21 | Bancroft; Michael R. | Ultrasonic catheter apparatus and method |
US6241718B1 (en) * | 1998-11-30 | 2001-06-05 | Cryocath Technologies, Inc. | Method for inhibiting restenosis |
US6428534B1 (en) * | 1999-02-24 | 2002-08-06 | Cryovascular Systems, Inc. | Cryogenic angioplasty catheter |
US6432102B2 (en) * | 1999-03-15 | 2002-08-13 | Cryovascular Systems, Inc. | Cryosurgical fluid supply |
US6468297B1 (en) * | 1999-02-24 | 2002-10-22 | Cryovascular Systems, Inc. | Cryogenically enhanced intravascular interventions |
US6726698B2 (en) * | 1999-03-02 | 2004-04-27 | Sound Surgical Technologies Llc | Pulsed ultrasonic device and method |
US6287302B1 (en) * | 1999-06-14 | 2001-09-11 | Fidus Medical Technology Corporation | End-firing microwave ablation instrument with horn reflection device |
US6270493B1 (en) * | 1999-07-19 | 2001-08-07 | Cryocath Technologies, Inc. | Cryoablation structure |
EP1207788A4 (en) * | 1999-07-19 | 2009-12-09 | St Jude Medical Atrial Fibrill | Apparatus and method for ablating tissue |
US6283959B1 (en) * | 1999-08-23 | 2001-09-04 | Cyrocath Technologies, Inc. | Endovascular cryotreatment catheter |
US20030065263A1 (en) * | 1999-10-05 | 2003-04-03 | Omnisonics Medical Technologies, Inc. | Ultrasonic probe device with rapid attachment and detachment means having a line contact collet |
US20040249401A1 (en) * | 1999-10-05 | 2004-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device with a non-compliant balloon |
US6263236B1 (en) * | 1999-11-29 | 2001-07-17 | Illumenex Corporation | Non-occlusive expandable catheter |
US6450975B1 (en) * | 1999-12-30 | 2002-09-17 | Advanced Cardiovascular Systems, Inc. | Ultrasonic transmission guide wire |
US6551309B1 (en) * | 2000-09-14 | 2003-04-22 | Cryoflex, Inc. | Dual action cryoprobe and methods of using the same |
US20040249372A1 (en) * | 2001-09-26 | 2004-12-09 | Leonilda Capuano | Method for treatment of aneurysms |
US6893436B2 (en) * | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
US20030236443A1 (en) * | 2002-04-19 | 2003-12-25 | Cespedes Eduardo Ignacio | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US20040158237A1 (en) * | 2003-02-11 | 2004-08-12 | Marwan Abboud | Multi-energy ablation station |
CA2519636A1 (en) * | 2003-03-27 | 2004-10-14 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
WO2006063199A2 (en) * | 2004-12-09 | 2006-06-15 | The Foundry, Inc. | Aortic valve repair |
US20080039727A1 (en) * | 2006-08-08 | 2008-02-14 | Eilaz Babaev | Ablative Cardiac Catheter System |
US20090131790A1 (en) * | 2007-05-15 | 2009-05-21 | Gynesonics, Inc. | Systems and methods for deploying echogenic components in ultrasonic imaging fields |
US20100016784A1 (en) * | 2008-07-17 | 2010-01-21 | Microcube Llc | Positionable medical system for positioning medical components on or within a body |
-
2006
- 2006-06-15 US US11/454,018 patent/US20080097251A1/en not_active Abandoned
-
2007
- 2007-06-14 WO PCT/US2007/071156 patent/WO2007147022A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3942519A (en) * | 1972-12-26 | 1976-03-09 | Ultrasonic Systems, Inc. | Method of ultrasonic cryogenic cataract removal |
US6514249B1 (en) * | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US20040243119A1 (en) * | 1999-08-23 | 2004-12-02 | Cryocath Technologies Inc. | Endovascular cryotreatment catheter |
US20040097996A1 (en) * | 1999-10-05 | 2004-05-20 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016124090B4 (en) * | 2016-12-12 | 2021-01-28 | Otto-Von-Guericke-Universität Magdeburg | Invasive medical instrument |
Also Published As
Publication number | Publication date |
---|---|
WO2007147022A3 (en) | 2008-11-20 |
US20080097251A1 (en) | 2008-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007147022A2 (en) | Method and apparatus for treating vascular obstructions | |
US11950793B2 (en) | Device and method for generating forward directed shock waves | |
US10702293B2 (en) | Two-stage method for treating calcified lesions within the wall of a blood vessel | |
US20230380849A1 (en) | Shockwave balloon catheter system | |
EP1009303B1 (en) | Circumferential ablation device assembly | |
JP4873816B2 (en) | Flexible tip catheter with guide wire tracking mechanism | |
US6383151B1 (en) | Circumferential ablation device assembly | |
US6997925B2 (en) | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall | |
US20130030431A1 (en) | Shock wave balloon catheter system with off center shock wave generator | |
US20060084966A1 (en) | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall | |
US20120203255A1 (en) | High pressure balloon shockwave catheter and method | |
US20020019627A1 (en) | Surgical ablation probe for forming a circumferential lesion | |
US20030195496A1 (en) | Apparatus and method incorporating an ultrasound transducer onto a delivery member | |
AU2001266824A1 (en) | Surgical ablation probe for forming a circumferential lesion | |
EP1769759A2 (en) | Apparatus and method incorporating an ultrasound transducer onto a delivery member | |
CN115192122A (en) | Shock wave balloon catheter device | |
CN220109803U (en) | Unidirectional impact waveguide tube | |
CN115252049A (en) | Forward burst wave generation system for treating occlusive lesions | |
Lynch et al. | Energy sources in urology 14 | |
MXPA00000305A (en) | Circumferential ablation device assembly and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07784435 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07784435 Country of ref document: EP Kind code of ref document: A2 |